Security key
45719W205
Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value per share (IKT)
CUSIP: 45719W205
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 235,004
- Total 13F value
- $298,925
- Share change
- -194,658
- SEC-reported price per share
- $1.27
- Number of holders
- 11
- Value change
- -$271,105
- Number of buys
- 5
- Number of sells
- 7
- Shares outstanding
- 148,020,141
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
11
Top holders
10
IKT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Inhibikase Therapeutics, Inc. SEC filings
Inhibikase Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45719W205
Recent filing periods:
Ownership snapshot
Top reported holders of IKT - Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
13/15
Latest evidence
30 Sep 2023
13F
3/4/5
Lead comparable stake: 0.13%
2 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 0.13%.
13 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
0.13%
VANGUARD GROUP INC
0.06%
BLAIR WILLIAM & CO/IL
0.04%
GEODE CAPITAL MANAGEMENT, LLC
0.02%
Redmond Asset Management, LLC
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
0.13%
|
$258,604
186,046 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
0.06%
|
$121,551
87,447 shares
|
— | 30 Sep 2023 |
| BLAIR WILLIAM & CO/IL |
13F
Company
|
0.04%
|
$82,531
59,375 shares
|
— | 30 Sep 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.02%
|
$40,488
28,692 shares
|
— | 30 Sep 2023 |
| Redmond Asset Management, LLC |
13F
Company
|
0.01%
|
$29,158
20,977 shares
|
— | 30 Sep 2023 |
| EDGEWOOD MANAGEMENT LLC |
13F
Company
|
0.01%
|
$23,166
16,666 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
235,004
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q1 2026 Across Filers
Q1 2026 holders
104
Q4 2023 holders
11
Holder diff
-93
| Investor | Q1 2026 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend